The World Association of Radiopharmaceutical and Molecular Therapy position statement on the initial radioiodine therapy for differentiated thyroid carcinoma
Loading...
Date
Authors
Dizdarevic, S.
Tulchinsky, M.
McCready, V.R.
Mihailovic, J,
Vinjamuri, S.
Buscombe, J.R.
Lee, S.T.
Frangos, S.
Sathekge, Mike Machaba
Siraj, Q.
Journal Title
Journal ISSN
Volume Title
Publisher
Medknow Publications
Abstract
The World Association of Radiopharmaceutical and Molecular
Therapy (WARMTH) is a worldwide nonprofit organization,
which is dedicated to educating medical professionals in
the use of radionuclide therapies based on the theragnostic
principles and to harmonizing appropriate evidence‑based
practices worldwide.
Description
Keywords
Cancer, World Association of Radiopharmaceutical and Molecular Therapy (WARMTH), Radioiodine therapy, Thyroid carcinoma
Sustainable Development Goals
Citation
Dizdarevic, S., Tulchinsky, M., McCready, V.R. et al. 2019, 'The World Association of Radiopharmaceutical and Molecular Therapy position statement on the initial radioiodine therapy for differentiated thyroid carcinoma', World Journal of Nuclear Medicine, vol. 18, no. 2, pp. 123-126.